Which has better valuation and earnings, ITGR or ATEC?

Integer has higher revenue and earnings than Alphatec. Alphatec is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Integer $1.85B 1.81 $102.81M $4.01 24.59 Alphatec $787.08M 1.61 -$143.36M -$0.82 N/A

Is ITGR or ATEC more profitable?

Integer has a net margin of 7.64% compared to Alphatec's net margin of -15.93%. Integer's return on equity of 12.83% beat Alphatec's return on equity. Company Net Margins Return on Equity Return on Assets Integer 7.64% 12.83% 6.51% Alphatec -15.93% -1,183.84% -15.83%

Does the media favor ITGR or ATEC?

In the previous week, Integer had 6 more articles in the media than Alphatec. MarketBeat recorded 9 mentions for Integer and 3 mentions for Alphatec. Integer's average media sentiment score of 1.69 beat Alphatec's score of 1.29 indicating that Integer is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Integer 6 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Alphatec 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor SMA or ATEC?

In the previous week, Smartstop Self Storage REIT had 1 more articles in the media than Alphatec. MarketBeat recorded 4 mentions for Smartstop Self Storage REIT and 3 mentions for Alphatec. Alphatec's average media sentiment score of 1.29 beat Smartstop Self Storage REIT's score of 0.96 indicating that Alphatec is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Smartstop Self Storage REIT 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Alphatec 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher earnings & valuation, ATRC or ATEC?

AtriCure has higher earnings, but lower revenue than Alphatec. AtriCure is trading at a lower price-to-earnings ratio than Alphatec, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio AtriCure $534.53M 3.32 -$11.45M -$0.10 N/A Alphatec $787.08M 1.61 -$143.36M -$0.82 N/A

Is ATRC or ATEC more profitable?

AtriCure has a net margin of 1.85% compared to Alphatec's net margin of -15.93%. AtriCure's return on equity of 2.37% beat Alphatec's return on equity. Company Net Margins Return on Equity Return on Assets AtriCure 1.85% 2.37% 1.79% Alphatec -15.93% -1,183.84% -15.83%

Does the media prefer ATRC or ATEC?

In the previous week, AtriCure had 9 more articles in the media than Alphatec. MarketBeat recorded 12 mentions for AtriCure and 3 mentions for Alphatec. Alphatec's average media sentiment score of 1.29 beat AtriCure's score of 0.79 indicating that Alphatec is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AtriCure 2 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Alphatec 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer ATEC or IART?

In the previous week, Integra LifeSciences had 4 more articles in the media than Alphatec. MarketBeat recorded 7 mentions for Integra LifeSciences and 3 mentions for Alphatec. Alphatec's average media sentiment score of 1.29 beat Integra LifeSciences' score of 0.53 indicating that Alphatec is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alphatec 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Integra LifeSciences 3 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is ATEC or ANGO more profitable?

AngioDynamics has a net margin of -11.48% compared to Alphatec's net margin of -15.93%. AngioDynamics' return on equity of -5.73% beat Alphatec's return on equity. Company Net Margins Return on Equity Return on Assets Alphatec -15.93% -1,183.84% -15.83% AngioDynamics -11.48% -5.73% -3.77%

Does the media refer more to ATEC or ANGO?

In the previous week, AngioDynamics had 1 more articles in the media than Alphatec. MarketBeat recorded 4 mentions for AngioDynamics and 3 mentions for Alphatec. Alphatec's average media sentiment score of 1.29 beat AngioDynamics' score of 0.25 indicating that Alphatec is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alphatec 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive AngioDynamics 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Alphatec (ATEC) Competitors

$8.26 +0.05 (+0.61%)

Closing price 07/24/2026 04:00 PM Eastern

Extended Trading

$8.26 0.00 (-0.06%)

As of 07/24/2026 07:34 PM Eastern

Compare

ATEC vs. ITGR, SMA, ATRC, IART, and ANGO

Should you buy Alphatec stock or one of its competitors? MarketBeat compares Alphatec with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Alphatec include Integer (ITGR), Smartstop Self Storage REIT (SMA), AtriCure (ATRC), Integra LifeSciences (IART), and AngioDynamics (ANGO). These companies are all part of the "health care equipment" industry.

How does Alphatec compare to Integer?

Integer (NYSE:ITGR) and Alphatec (NASDAQ:ATEC) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, earnings, media sentiment, dividends, profitability, institutional ownership and valuation.

99.3% of Integer shares are held by institutional investors. Comparatively, 66.3% of Alphatec shares are held by institutional investors. 1.1% of Integer shares are held by company insiders. Comparatively, 13.5% of Alphatec shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Integer has higher revenue and earnings than Alphatec. Alphatec is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integer	$1.85B	1.81	$102.81M	$4.01	24.59
Alphatec	$787.08M	1.61	-$143.36M	-$0.82	N/A

Integer has a beta of 0.64, meaning that its share price is 36% less volatile than the broader market. Comparatively, Alphatec has a beta of 0.85, meaning that its share price is 15% less volatile than the broader market.

Integer has a net margin of 7.64% compared to Alphatec's net margin of -15.93%. Integer's return on equity of 12.83% beat Alphatec's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Integer	7.64%	12.83%	6.51%
Alphatec	-15.93%	-1,183.84%	-15.83%

Integer currently has a consensus price target of $97.00, indicating a potential downside of 1.63%. Alphatec has a consensus price target of $17.29, indicating a potential upside of 109.27%. Given Alphatec's stronger consensus rating and higher probable upside, analysts plainly believe Alphatec is more favorable than Integer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integer	0 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.54
Alphatec	1 Sell rating(s)	1 Hold rating(s)	10 Buy rating(s)	2 Strong Buy rating(s)	2.93

In the previous week, Integer had 6 more articles in the media than Alphatec. MarketBeat recorded 9 mentions for Integer and 3 mentions for Alphatec. Integer's average media sentiment score of 1.69 beat Alphatec's score of 1.29 indicating that Integer is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Integer	6 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Alphatec	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Integer beats Alphatec on 11 of the 17 factors compared between the two stocks.

How does Alphatec compare to Smartstop Self Storage REIT?

Smartstop Self Storage REIT (NYSE:SMA) and Alphatec (NASDAQ:ATEC) are both small-cap health care equipment companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, profitability, risk, earnings, valuation, institutional ownership and media sentiment.

Smartstop Self Storage REIT has higher earnings, but lower revenue than Alphatec. Alphatec is trading at a lower price-to-earnings ratio than Smartstop Self Storage REIT, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Smartstop Self Storage REIT	$294.00M	6.54	-$1.55M	$0.15	231.53
Alphatec	$787.08M	1.61	-$143.36M	-$0.82	N/A

66.3% of Alphatec shares are held by institutional investors. 5.7% of Smartstop Self Storage REIT shares are held by insiders. Comparatively, 13.5% of Alphatec shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Smartstop Self Storage REIT had 1 more articles in the media than Alphatec. MarketBeat recorded 4 mentions for Smartstop Self Storage REIT and 3 mentions for Alphatec. Alphatec's average media sentiment score of 1.29 beat Smartstop Self Storage REIT's score of 0.96 indicating that Alphatec is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Smartstop Self Storage REIT	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Alphatec	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Smartstop Self Storage REIT currently has a consensus target price of $36.44, indicating a potential upside of 4.92%. Alphatec has a consensus target price of $17.29, indicating a potential upside of 109.27%. Given Alphatec's stronger consensus rating and higher possible upside, analysts clearly believe Alphatec is more favorable than Smartstop Self Storage REIT.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Smartstop Self Storage REIT	1 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	2 Strong Buy rating(s)	2.70
Alphatec	1 Sell rating(s)	1 Hold rating(s)	10 Buy rating(s)	2 Strong Buy rating(s)	2.93

Smartstop Self Storage REIT has a beta of 0.56, suggesting that its stock price is 44% less volatile than the broader market. Comparatively, Alphatec has a beta of 0.85, suggesting that its stock price is 15% less volatile than the broader market.

Smartstop Self Storage REIT has a net margin of 4.38% compared to Alphatec's net margin of -15.93%. Smartstop Self Storage REIT's return on equity of 1.00% beat Alphatec's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Smartstop Self Storage REIT	4.38%	1.00%	0.54%
Alphatec	-15.93%	-1,183.84%	-15.83%

Summary

Smartstop Self Storage REIT and Alphatec tied by winning 8 of the 16 factors compared between the two stocks.

How does Alphatec compare to AtriCure?

AtriCure (NASDAQ:ATRC) and Alphatec (NASDAQ:ATEC) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, profitability, risk, analyst recommendations, dividends and media sentiment.

In the previous week, AtriCure had 9 more articles in the media than Alphatec. MarketBeat recorded 12 mentions for AtriCure and 3 mentions for Alphatec. Alphatec's average media sentiment score of 1.29 beat AtriCure's score of 0.79 indicating that Alphatec is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AtriCure	2 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Alphatec	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

99.1% of AtriCure shares are owned by institutional investors. Comparatively, 66.3% of Alphatec shares are owned by institutional investors. 4.0% of AtriCure shares are owned by company insiders. Comparatively, 13.5% of Alphatec shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

AtriCure has a beta of 1.24, suggesting that its share price is 24% more volatile than the broader market. Comparatively, Alphatec has a beta of 0.85, suggesting that its share price is 15% less volatile than the broader market.

AtriCure has higher earnings, but lower revenue than Alphatec. AtriCure is trading at a lower price-to-earnings ratio than Alphatec, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AtriCure	$534.53M	3.32	-$11.45M	-$0.10	N/A
Alphatec	$787.08M	1.61	-$143.36M	-$0.82	N/A

AtriCure has a net margin of 1.85% compared to Alphatec's net margin of -15.93%. AtriCure's return on equity of 2.37% beat Alphatec's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AtriCure	1.85%	2.37%	1.79%
Alphatec	-15.93%	-1,183.84%	-15.83%

AtriCure currently has a consensus price target of $49.13, indicating a potential upside of 40.20%. Alphatec has a consensus price target of $17.29, indicating a potential upside of 109.27%. Given Alphatec's stronger consensus rating and higher possible upside, analysts plainly believe Alphatec is more favorable than AtriCure.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AtriCure	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.64
Alphatec	1 Sell rating(s)	1 Hold rating(s)	10 Buy rating(s)	2 Strong Buy rating(s)	2.93

Summary

AtriCure beats Alphatec on 10 of the 17 factors compared between the two stocks.

How does Alphatec compare to Integra LifeSciences?

Alphatec (NASDAQ:ATEC) and Integra LifeSciences (NASDAQ:IART) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, dividends, earnings, analyst recommendations, profitability, media sentiment, institutional ownership and risk.

Alphatec has higher earnings, but lower revenue than Integra LifeSciences. Alphatec is trading at a lower price-to-earnings ratio than Integra LifeSciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alphatec	$787.08M	1.61	-$143.36M	-$0.82	N/A
Integra LifeSciences	$1.64B	0.94	-$516.47M	-$6.46	N/A

Alphatec has a net margin of -15.93% compared to Integra LifeSciences' net margin of -30.15%. Integra LifeSciences' return on equity of 17.42% beat Alphatec's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alphatec	-15.93%	-1,183.84%	-15.83%
Integra LifeSciences	-30.15%	17.42%	5.00%

Alphatec presently has a consensus target price of $17.29, suggesting a potential upside of 109.27%. Integra LifeSciences has a consensus target price of $18.33, suggesting a potential downside of 7.36%. Given Alphatec's stronger consensus rating and higher possible upside, analysts clearly believe Alphatec is more favorable than Integra LifeSciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alphatec	1 Sell rating(s)	1 Hold rating(s)	10 Buy rating(s)	2 Strong Buy rating(s)	2.93
Integra LifeSciences	2 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.86

Alphatec has a beta of 0.85, indicating that its stock price is 15% less volatile than the broader market. Comparatively, Integra LifeSciences has a beta of 1.22, indicating that its stock price is 22% more volatile than the broader market.

66.3% of Alphatec shares are held by institutional investors. Comparatively, 84.8% of Integra LifeSciences shares are held by institutional investors. 13.5% of Alphatec shares are held by company insiders. Comparatively, 3.8% of Integra LifeSciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, Integra LifeSciences had 4 more articles in the media than Alphatec. MarketBeat recorded 7 mentions for Integra LifeSciences and 3 mentions for Alphatec. Alphatec's average media sentiment score of 1.29 beat Integra LifeSciences' score of 0.53 indicating that Alphatec is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alphatec	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Integra LifeSciences	3 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Alphatec beats Integra LifeSciences on 10 of the 17 factors compared between the two stocks.

How does Alphatec compare to AngioDynamics?

Alphatec (NASDAQ:ATEC) and AngioDynamics (NASDAQ:ANGO) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, analyst recommendations, valuation, earnings, risk, institutional ownership, profitability and media sentiment.

66.3% of Alphatec shares are owned by institutional investors. Comparatively, 89.4% of AngioDynamics shares are owned by institutional investors. 13.5% of Alphatec shares are owned by company insiders. Comparatively, 6.0% of AngioDynamics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

AngioDynamics has a net margin of -11.48% compared to Alphatec's net margin of -15.93%. AngioDynamics' return on equity of -5.73% beat Alphatec's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alphatec	-15.93%	-1,183.84%	-15.83%
AngioDynamics	-11.48%	-5.73%	-3.77%

In the previous week, AngioDynamics had 1 more articles in the media than Alphatec. MarketBeat recorded 4 mentions for AngioDynamics and 3 mentions for Alphatec. Alphatec's average media sentiment score of 1.29 beat AngioDynamics' score of 0.25 indicating that Alphatec is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alphatec	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
AngioDynamics	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

AngioDynamics has lower revenue, but higher earnings than Alphatec. AngioDynamics is trading at a lower price-to-earnings ratio than Alphatec, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alphatec	$787.08M	1.61	-$143.36M	-$0.82	N/A
AngioDynamics	$320.17M	1.75	-$36.74M	-$0.87	N/A

Alphatec has a beta of 0.85, suggesting that its stock price is 15% less volatile than the broader market. Comparatively, AngioDynamics has a beta of 0.34, suggesting that its stock price is 66% less volatile than the broader market.

Alphatec presently has a consensus price target of $17.29, indicating a potential upside of 109.27%. AngioDynamics has a consensus price target of $19.50, indicating a potential upside of 43.49%. Given Alphatec's stronger consensus rating and higher possible upside, equities analysts plainly believe Alphatec is more favorable than AngioDynamics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alphatec	1 Sell rating(s)	1 Hold rating(s)	10 Buy rating(s)	2 Strong Buy rating(s)	2.93
AngioDynamics	2 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.40

Summary

Alphatec beats AngioDynamics on 10 of the 17 factors compared between the two stocks.

Get Alphatec News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ATEC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ATEC vs. The Competition

Export

Metric	Alphatec	MED INSTRUMENTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$1.27B	$7.30B	$6.87B	$12.26B
Dividend Yield	N/A	1.33%	2.67%	9.79%
P/E Ratio	-10.07	48.63	27.11	23.64
Price / Sales	1.61	96.88	512.89	89.27
Price / Cash	N/A	25.71	50.54	59.64
Price / Book	103.25	6.73	10.28	6.07
Net Income	-$143.36M	$162.27M	$3.60B	$331.99M
7 Day Performance	-3.17%	-5.05%	-1.27%	-0.63%
1 Month Performance	-6.46%	-5.86%	-0.37%	-2.00%
1 Year Performance	-23.66%	-2.88%	18.30%	13.62%

Alphatec Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ATEC Alphatec	4.0259 of 5 stars	$8.26 +0.6%	$17.29 +109.3%	-22.9%	$1.27B	$787.08M	N/A	700	Positive News Analyst Upgrade
ITGR Integer	2.3877 of 5 stars	$96.40 +2.9%	$99.29 +3.0%	-8.2%	$3.18B	$1.85B	24.04	11,000	News Coverage Analyst Forecast
SMA Smartstop Self Storage REIT	2.7958 of 5 stars	$33.14 +0.5%	$36.81 +11.1%	-6.5%	$1.83B	$281.14M	220.93	N/A	News Coverage Analyst Forecast
ATRC AtriCure	3.7216 of 5 stars	$34.80 +1.5%	$48.71 +40.0%	+16.1%	$1.74B	$534.53M	N/A	1,300	Trending News Earnings Report Analyst Forecast Gap Up
IART Integra LifeSciences	1.4129 of 5 stars	$18.58 -1.1%	$17.17 -7.6%	+55.7%	$1.46B	$1.64B	N/A	4,427	News Coverage Upcoming Earnings

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ATEC) was last updated on 7/25/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Alphatec (ATEC) Competitors

ATEC vs. ITGR, SMA, ATRC, IART, and ANGO

How does Alphatec compare to Integer?

Summary

How does Alphatec compare to Smartstop Self Storage REIT?

Summary

How does Alphatec compare to AtriCure?

Summary

How does Alphatec compare to Integra LifeSciences?

Summary

How does Alphatec compare to AngioDynamics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ATEC vs. The Competition

Alphatec Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Alphatec (ATEC) Competitors

ATEC vs. ITGR, SMA, ATRC, IART, and ANGO

How does Alphatec compare to Integer?

Do institutionals & insiders have more ownership in ITGR or ATEC?

Which has better valuation and earnings, ITGR or ATEC?

Which has more risk & volatility, ITGR or ATEC?

Is ITGR or ATEC more profitable?

Do analysts prefer ITGR or ATEC?

Does the media favor ITGR or ATEC?

Summary

How does Alphatec compare to Smartstop Self Storage REIT?

Which has preferable valuation and earnings, SMA or ATEC?

Do institutionals & insiders have more ownership in SMA or ATEC?

Does the media favor SMA or ATEC?

Do analysts prefer SMA or ATEC?

Which has more volatility & risk, SMA or ATEC?

Is SMA or ATEC more profitable?

Summary

How does Alphatec compare to AtriCure?

Does the media prefer ATRC or ATEC?

Do institutionals & insiders have more ownership in ATRC or ATEC?

Which has more volatility & risk, ATRC or ATEC?

Which has higher earnings & valuation, ATRC or ATEC?

Is ATRC or ATEC more profitable?

Do analysts recommend ATRC or ATEC?

Summary

How does Alphatec compare to Integra LifeSciences?

Which has stronger earnings and valuation, ATEC or IART?

Is ATEC or IART more profitable?

Do analysts recommend ATEC or IART?

Which has more volatility and risk, ATEC or IART?

Do insiders & institutionals hold more shares of ATEC or IART?

Does the media prefer ATEC or IART?

Summary

How does Alphatec compare to AngioDynamics?

Do insiders and institutionals believe in ATEC or ANGO?

Is ATEC or ANGO more profitable?

Does the media refer more to ATEC or ANGO?

Which has better valuation and earnings, ATEC or ANGO?

Which has more volatility & risk, ATEC or ANGO?

Do analysts recommend ATEC or ANGO?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ATEC vs. The Competition

Alphatec Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools